LNTH

Lantheus Holdings
LNTH

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$6.94B
EV
$6.65B
Shares Outstanding
70.59M
Beta
0.20

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$134.38
P/E 2025E
14.45x
P/Revenue 2025E
4.37x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lantheus Holdings, Inc.

gainify
LNTH

Lantheus Holdings, Inc.

LNTH

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Markison, Brian

Employees

808

IPO Date

2015-06-25

Headquarters

201 Burlington Road, South Building, Bedford, Massachusetts, 01730, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved